Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(33.3%)
Phase 3
1(33.3%)
Phase 2
1(33.3%)
3Total
N/A(1)
Phase 3(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02018913Unknown

Blood-brain Barrier Leakage in Dementia. A Dynamic Contrast-enhanced MRI Study

Role: collaborator

NCT00554047Not ApplicableCompleted

Comparison of Effectiveness and Costs of Post-diagnosis Treatment in Dementia

Role: collaborator

NCT00285753Phase 2Completed

Support Groups for Patients With Mild Cognitive Impairment and Their Partners

Role: collaborator

NCT00432081Phase 3Completed

Effect of Indomethacin on the Progression of Alzheimer's Disease

Role: collaborator

All 4 trials loaded